Stockscreener 앱 받기
674.60
0.32%
-2.175
Medpace Holdings Inc 주식(MEDP)의 최신 뉴스
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes" - Zacks Investment Research
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy - Zacks Investment Research
Medpace: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates - Zacks Investment Research
Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October - Investing.com Canada
Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October - Investing.com UK
At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares. - Stock Titan
CON vs. MEDP: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
Medpace (MEDP) Dips More Than Broader Market: What You Should Know - Zacks Investment Research
At $166.73 per share, Medpace (MEDP) EVP Susan E. Burwig exercises options for 2,000 shares. - Stock Titan
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors - Zacks Investment Research
After converting stock units into 28 shares, Medpace (MEDP) director McCarthy holds 12,303 shares directly. - Stock Titan
After a 32-share grant conversion, Medpace (MEDP) director Kraft holds 987 shares directly. - Stock Titan
After a 36-share conversion, Medpace (MEDP) director Carley holds 27,861 common shares. - Stock Titan
Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com South Africa
Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com Nigeria
Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com South Africa
Medpace Holdings CEO August Troendle sells $30.3m in stock - Investing.com
Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Australia
Two days of CEO share sales at Medpace (MEDP) were executed through an open-window limit order. - Stock Titan
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Zacks Investment Research
At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan
Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria
Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com
Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com
Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com India
Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com UK
CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan
After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan
Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan
MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile
MEDP DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile
Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Zacks Investment Research
Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - stocktitan.net
Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal
Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - stocktitan.net
Medpace Holdings (MEDP) insider exercises 3,000 options - stocktitan.net
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years - Benzinga
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMEDP - Eastern Progress
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky - Eastern Progress
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Medpace Deadline: MEDP Investors with Losses in Excess of $100K Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - Eastern Progress
Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential - DirectorsTalk Interviews
MEDP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Medpace Holdings, Inc. Securities LawsuitContact The Gross Law Firm - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc. (MEDP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
0.51%
0.42%
자본화:
|
볼륨(24시간):